https://www.deepgenomics.com | Canada | 2014 | $227.47M
Deep Genomics is a biotechnology company based in Toronto, Canada that develops individualized genetic medicines using advanced artificial intelligence (AI) systems. The company has built an AI-powered discovery platform that supports researchers and drug developers across all stages of the drug discovery and development process, from target identification to lead optimization and toxicity assessment. Deep Genomics has leveraged its proprietary AI technology to make the first-ever AI-driven discovery of a treatment for a rare genetic disorder, demonstrating the potential of its approach. The company has raised significant funding from investors and is focused on expanding its AI platform and advancing its pipeline of AI-discovered therapeutic candidates.
